|
Volumn 64, Issue 14, 2007, Pages 1460-1461
|
Panel advises against rimonabant approval
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIDEPRESSANT AGENT;
ANXIOLYTIC AGENT;
CANNABINOID 1 RECEPTOR;
CANNABINOID RECEPTOR ANTAGONIST;
CP 945598;
CP 975598;
ENDOCANNABINOID;
PLACEBO;
RIMONABANT;
TARANABANT;
UNCLASSIFIED DRUG;
ANXIETY DISORDER;
CLINICAL TRIAL;
COGNITIVE DEFECT;
DEPRESSION;
DIET THERAPY;
DRUG APPROVAL;
DRUG EFFECT;
DRUG SAFETY;
EXERCISE;
FOOD AND DRUG ADMINISTRATION;
HUMAN;
LIFESTYLE;
LIFESTYLE MODIFICATION;
METABOLIC SYNDROME X;
NEUROLOGIC DISEASE;
NOTE;
OBESITY;
PRIORITY JOURNAL;
SUICIDAL BEHAVIOR;
UNITED STATES;
WEIGHT REDUCTION;
|
EID: 34447574994
PISSN: 10792082
EISSN: None
Source Type: Journal
DOI: 10.2146/news070065 Document Type: Note |
Times cited : (20)
|
References (0)
|